Better health outcomes through more effective and efficient research as seen throughout the pandemic
Promoting a patient-centred, innovative and data-enabled clinical research environment
Embedding research in the NHS to increase UK’s capacity and capability to deliver cutting-edge clinical research
Patients across the UK will benefit from a super-charged clinical research system, backed by over £64 million of dedicated investment, which will save lives across the country.
The activity for the coming months will include:
the development and trial of new COVID-19 treatments and vaccines
making UK clinical research delivery easier through more rapid ethics reviews and faster approval processes
boosting clinical research capacity with more virtual and remote trials
UK government sets out bold vision for the future of clinical research delivery gov.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gov.uk Daily Mail and Mail on Sunday newspapers.
Patients are needed for a new Covid trial HEALTH chiefs have issued an appeal for people in Dumbarton and the Vale who have recently been diagnosed with Covid-19 to take part in a treatment trial. Researchers from NHS Greater Glasgow and Clyde are recruiting members of the public to help evaluate the effectiveness of antiviral tablet favipiravir in managing the disease. The medication targets the early stages of infection and must be taken within four days of a positive result. It is intended for people with milder symptoms who can safely take part from home. Half the patients involved will receive the drug twice a day for ten days alongside standard treatment, with the other half receiving standard treatment for comparison.
Antiviral tablet Favipiravir is already used in Japan for flu, and is made by Fujifilm Toyama Chemicals. It is now being trialled for use in Covid patients with milder symptoms by scientists in Glasgow who hope it could stop them developing serious ones. It has to be taken within four days of a positive test and NHS Greater Glasgow and Clyde and the University of Glasgow are urging people who have been diagnosed with the infection to take part in a new study. The tablet can be taken at home, twice a day, and is intended for people with milder symptoms than those requiring hospital admission.